A Study of LY3041658 in Adults With Hidradenitis Suppurativa
Recruitment Status: Recruiting
Estimated Study Completion Date: July 4, 2022
HS Connect listed this: October 2020
Sponsor: Eli Lilly and Company
Information provided by (Responsible Party):Eli Lilly and Company
The reason for this study is to see if the study drug LY3041658 is effective in participants with moderate-to-severe hidradenitis suppurativa (HS).
Please link for complete trial details:
Location: Multiple US locations. Please see link above for all location details and to confirm your location is recruiting.
Contact: 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559